Can a DIY fertility test help you plan when to have a baby?
By Zoë Corbyn,
The Guardian
| 01. 21. 2018
My sisters, aged 27 and 30, are seated at their computers poring over the slick websites of companies promising to reveal secrets to them about their fertility. “Get insight into how your fertility is tracking relative to your age,” promises one. “Get the tools you need to have more control over your fertility,” says a second. “Gauge how long you have left to conceive,” says a third. The tests, which look at the levels of one or more female hormones in the blood, style themselves as easy to order and are less than what one would pay in a fertility clinic. “The information seems relatively cheap and readily available, so why not find out?” says my older sister. “I just assumed I wouldn’t have any fertility issues,” says the younger. “I realise after looking at these websites I probably shouldn’t assume this.”
These companies are the latest outgrowth of the growing global market in fertility services. Fuelled by women delaying childbirth longer, it includes IVF and egg freezing and is expected to generate $21bn (£15.5bn) in revenue globally by 2020...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...